Hangzhou-headquartered Santo Therapeutics, which has a base at Stevenage Bioscience Catalyst, says its lead program, ST002, ...
Utah-based Vector Defense is pioneering a service-based model for delivering and upgrading military drones, bypassing lengthy ...
By David Kirton SHENZHEN, April 30 (Reuters) - An American scientist convicted of lying to U.S. authorities about payments ...
Conjugation of universal, functionally de-targeted OneAAVTM capsid provides on-demand specificity and scalabilityto address ...
NEWS10 ABC on MSN
Department of Health tracks tick activity as tick season ramps up
Research scientists with the New York State Department of Health (NYSDOH) were out in the field on Monday, sweeping for ticks ...
Groundbreaking AAV-based gene therapy offers potential treatment for patients with OTOF gene-associated severe-to-profound and profound hearing lossWhite Oak, Md., April 24, 2026 (GLOBE NEWSWIRE) -- ...
SmartRent today announced the launch of its strategic value-added reseller program to serve small and mid-market multifamily owners and operators.
Hopland Research and Extension Center invites the community to an open house on May 17, from 10 a.m. to 2 p.m, to mark 75 ...
First quarter 2026 revenues increased 19% to $3.6 billion versus first quarter 2025Dupixent® global net sales(recorded by Sanofi) increased 33% ...
When it comes to matching the commercial scale-up to the innovations taking place across Kite’s pipeline, Alquist admitted ...
Turkey’s trajectory is not dependent on the outcome of the Iranian case - it is a function of its desire to claim leadership ...
The FDA has approved Otarmeni, the first-ever gene therapy for genetic hearing loss caused by the OTOF gene, for both ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results